Passa al contenuto
Merck

Vai a

G3002

Gly-Pro

≥98%, suitable for ligand binding assays

Sinonimo/i:

glycyl-L-proline

Autenticati per visualizzare i prezzi organizzativi e contrattuali.

Scegli un formato

Cambia visualizzazione
Taglio della confezioneSKUDisponibilitàPrezzo
10 g
Per conoscere la disponibilità, visualizza il carrello
CHF 811.00

Informazioni su questo articolo

Formula empirica (notazione di Hill):
C7H12N2O3
Numero CAS:
Peso molecolare:
172.18
MDL number:
UNSPSC Code:
12352202
PubChem Substance ID:
NACRES:
NA.26
EC Number:
211-880-2

CHF 811.00


Per conoscere la disponibilità, visualizza il carrello

Richiedi un ordine in blocco
Servizio Tecnico
Hai bisogno di aiuto? Il nostro team di scienziati qualificati è a tua disposizione.
Permettici di aiutarti


Nome del prodotto

Gly-Pro,

assay

≥98%

Quality Level

form

solid

technique(s)

ligand binding assay: suitable

color

white

storage temp.

−20°C

SMILES string

NCC(N1[C@H](C(O)=O)CCC1)=O

InChI

1S/C7H12N2O3/c8-4-6(10)9-3-1-2-5(9)7(11)12/h5H,1-4,8H2,(H,11,12)

InChI key

KZNQNBZMBZJQJO-UHFFFAOYSA-N

Application


  • Diagnostic efficacy of [(68)Ga]Ga-DOTA-GPFAPI-04 in patients with solid tumors in a head-to-head comparison with [(18)F]F-FDG: results from a prospective clinical study.: This study explores the use of Gly-Pro in peptide imaging agents, specifically [(68)Ga]Ga-DOTA-GPFAPI-04, demonstrating its superior diagnostic performance in detecting solid tumors compared to traditional imaging modalities, offering new avenues for cancer diagnosis and monitoring (Yuan et al., 2024).

  • Understanding the Transepithelial Transport and Transbilayer Diffusion of the Antihypertensive Peptide Asn-Cys-Trp: Insights from Caco-2 Cell Monolayers and the DPPC Model Membrane.: This research demonstrates the utility of Gly-Pro in studying the absorption and metabolic stability of antihypertensive peptides, providing key insights into their pharmacokinetic behaviors and enhancing drug delivery strategies (Wu et al., 2024).


Confronta articoli simili

Visualizza il confronto per intero

Mostra le differenze

1 of 1

Questo articolo
50200P2254G0903
Gly-Pro

Sigma-Aldrich

G3002

Gly-Pro

Gly-Gly BioXtra, ≥99.0% (NT)

Sigma-Aldrich

50200

Gly-Gly

Poly-L-proline mol wt 1,000-10,000

Sigma-Aldrich

P2254

Poly-L-proline

γ-Glu-Cys ≥80% (HPLC)

Sigma-Aldrich

G0903

γ-Glu-Cys

form

solid

form

powder

form

powder

form

powder

assay

≥98%

assay

≥99.0% (NT)

assay

-

assay

≥80% (HPLC)

technique(s)

ligand binding assay: suitable

technique(s)

ligand binding assay: suitable

technique(s)

ligand binding assay: suitable

technique(s)

ligand binding assay: suitable

storage temp.

−20°C

storage temp.

-

storage temp.

−20°C

storage temp.

−20°C

color

white

color

white

color

white

color

white to off-white

Quality Level

200

Quality Level

200

Quality Level

200

Quality Level

200


pictograms

Exclamation mark

signalword

Warning

hcodes

Hazard Classifications

Eye Irrit. 2

Classe di stoccaggio

11 - Combustible Solids

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

ppe

dust mask type N95 (US), Eyeshields, Gloves



Scegli una delle versioni più recenti:

Certificati d'analisi (COA)

Lot/Batch Number

Non trovi la versione di tuo interesse?

Se hai bisogno di una versione specifica, puoi cercare il certificato tramite il numero di lotto.

Possiedi già questo prodotto?

I documenti relativi ai prodotti acquistati recentemente sono disponibili nell’Archivio dei documenti.

Visita l’Archivio dei documenti



E Berardesca et al.
The British journal of dermatology, 126(2), 193-195 (1992-02-01)
A case is reported of a 15-year-old boy with prolidase deficiency and marked urinary excretion of the iminodipeptide gly-pro. Prolidase activity of erythrocytes against substrate glycyl-proline was deficient, but after blood transfusions this was increased to 15.7% of donor activity
Poonam Kalhotra et al.
Biomolecules, 10(2) (2020-02-23)
Diabetes mellitus is a severe health problem in Mexico, and its prevalence is increasing exponentially every year. Recently, DPP-4 (dipeptidyl peptidase-4) inhibitors have become attractive oral anti-hyperglycemic agents to reduce the pathology of diabetes. Gliptin's family, such as sitagliptin, vildagliptin
Rong Qiu et al.
Scientific reports, 10(1), 8231-8231 (2020-05-20)
In this study, we used a new coating agent, that is, ultra-purified alginate gel (UPAL), for fetal liver tissue transplantation. This study aims to compare the effect of UPAL with the effect of other coating agents on improving the effect



Numero articolo commerciale globale

SKUGTIN
G3002-10G04061838354587

Questions

Reviews

No rating value

Active Filters